Tang X - Search Results

1

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.

Lu C, Soria JC, Tang X, Xu XC, Wang L, Mao L, Lotan R, Kemp B, Bekele BN, Feng L, Hong WK, Khuri FR. Lu C, et al. Among authors: tang x. J Clin Oncol. 2004 Nov 15;22(22):4575-83. doi: 10.1200/JCO.2004.01.091. J Clin Oncol. 2004. PMID: 15542809

2

Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer.

Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L. Tang X, et al. J Natl Cancer Inst. 2000 Sep 20;92(18):1511-6. doi: 10.1093/jnci/92.18.1511. J Natl Cancer Inst. 2000. PMID: 10995806

3

Loss of Fhit expression is a predictor of poor outcome in tongue cancer.

Lee JI, Soria JC, Hassan K, Liu D, Tang X, El-Naggar A, Hong WK, Mao L. Lee JI, et al. Among authors: tang x. Cancer Res. 2001 Feb 1;61(3):837-41. Cancer Res. 2001. PMID: 11221865

4

Loss of PTEN expression as a prognostic marker for tongue cancer.

Lee JI, Soria JC, Hassan KA, El-Naggar AK, Tang X, Liu DD, Hong WK, Mao L. Lee JI, et al. Among authors: tang x. Arch Otolaryngol Head Neck Surg. 2001 Dec;127(12):1441-5. doi: 10.1001/archotol.127.12.1441. Arch Otolaryngol Head Neck Surg. 2001. PMID: 11735811

5

Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.

Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L. Wu W, et al. Among authors: tang x. Clin Exp Metastasis. 2002;19(4):319-26. doi: 10.1023/a:1015515119300. Clin Exp Metastasis. 2002. PMID: 12090472

6

Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.

Soria JC, Moon C, Kemp BL, Liu DD, Feng L, Tang X, Chang YS, Mao L, Khuri FR. Soria JC, et al. Among authors: tang x. Clin Cancer Res. 2003 May;9(5):1785-91. Clin Cancer Res. 2003. PMID: 12738735

7

Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.

Ren H, Tang X, Lee JJ, Feng L, Everett AD, Hong WK, Khuri FR, Mao L. Ren H, et al. Among authors: tang x. J Clin Oncol. 2004 Aug 15;22(16):3230-7. doi: 10.1200/JCO.2004.02.080. J Clin Oncol. 2004. PMID: 15310766

8

Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.

Tang X, Wu W, Sun SY, Wistuba II, Hong WK, Mao L. Tang X, et al. Mol Cancer Res. 2004 Dec;2(12):685-91. Mol Cancer Res. 2004. PMID: 15634757

9

EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.

Tang X, Shigematsu H, Bekele BN, Roth JA, Minna JD, Hong WK, Gazdar AF, Wistuba II. Tang X, et al. Cancer Res. 2005 Sep 1;65(17):7568-72. doi: 10.1158/0008-5472.CAN-05-1705. Cancer Res. 2005. PMID: 16140919

10

Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.

Tang X, Liu D, Shishodia S, Ozburn N, Behrens C, Lee JJ, Hong WK, Aggarwal BB, Wistuba II. Tang X, et al. Cancer. 2006 Dec 1;107(11):2637-46. doi: 10.1002/cncr.22315. Cancer. 2006. PMID: 17078054 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,210 results

Search Page

Filters